Denali Therapeutics (DNLI) EBITDA Margin Growth (1y) (2019 - 2023)
Denali Therapeutics (DNLI) EBITDA Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -579,668.00 |
| Jun 30, 2023 | 17,499.00 |
| Mar 31, 2023 | -18,600.00 |
| Dec 31, 2022 | -89,493.00 |
| Sep 30, 2022 | -156,522.00 |
| Jun 30, 2022 | 29,509.00 |
| Mar 31, 2022 | 74,122.00 |
| Dec 31, 2021 | -23,555.00 |
| Sep 30, 2021 | -97,920.00 |
| Jun 30, 2021 | 64,239.00 |
| Mar 31, 2021 | 11.44 Mn |
| Dec 31, 2020 | 131,330.00 |
| Sep 30, 2020 | 51,027.00 |
| Jun 30, 2020 | 47,705.00 |
| Mar 31, 2020 | -11.43 Mn |
| Dec 31, 2019 | -129,571.00 |
| Sep 30, 2019 | 202,628.00 |
| Jun 30, 2019 | 195,037.00 |
| Mar 31, 2019 | 300,596.00 |